ID30485A - Kombinasi obat yang terdiri dari ( e ) 7 [ 4 ( 4 fluorofenil ) 6 isopropil 2 [ metil (metilsulfonil) - amino ] pirimidin 5 il ] (3r,5s) 3,5 dihidroksihept-6- asam enoik dan suatu penghambat, bahat penginduksi atau bahan dari p450 isoenzim 3a4 - Google Patents

Kombinasi obat yang terdiri dari ( e ) 7 [ 4 ( 4 fluorofenil ) 6 isopropil 2 [ metil (metilsulfonil) - amino ] pirimidin 5 il ] (3r,5s) 3,5 dihidroksihept-6- asam enoik dan suatu penghambat, bahat penginduksi atau bahan dari p450 isoenzim 3a4

Info

Publication number
ID30485A
ID30485A IDW00200101892A ID20011892A ID30485A ID 30485 A ID30485 A ID 30485A ID W00200101892 A IDW00200101892 A ID W00200101892A ID 20011892 A ID20011892 A ID 20011892A ID 30485 A ID30485 A ID 30485A
Authority
ID
Indonesia
Prior art keywords
pyrimidine
amino
metylsulfonyl
methodsulfonyl
isoenzim
Prior art date
Application number
IDW00200101892A
Other languages
English (en)
Indonesian (id)
Inventor
Ali Raza
John Stuart Pears
Howard Gerard Hutchinson
Dennis Schneck
Takahiko Baba
Akira Touchi
Yoshitaka Yamaguchi
Original Assignee
Astrazeneca Ab
Shionogi & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27269637&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ID30485(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GBGB9902593.4A external-priority patent/GB9902593D0/en
Priority claimed from GBGB9921064.3A external-priority patent/GB9921064D0/en
Priority claimed from GBGB9921063.5A external-priority patent/GB9921063D0/en
Application filed by Astrazeneca Ab, Shionogi & Co filed Critical Astrazeneca Ab
Publication of ID30485A publication Critical patent/ID30485A/id

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4402—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 2, e.g. pheniramine, bisacodyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Transplantation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
IDW00200101892A 1999-02-06 2000-02-01 Kombinasi obat yang terdiri dari ( e ) 7 [ 4 ( 4 fluorofenil ) 6 isopropil 2 [ metil (metilsulfonil) - amino ] pirimidin 5 il ] (3r,5s) 3,5 dihidroksihept-6- asam enoik dan suatu penghambat, bahat penginduksi atau bahan dari p450 isoenzim 3a4 ID30485A (id)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9902593.4A GB9902593D0 (en) 1999-02-06 1999-02-06 Drug combinations
GBGB9921064.3A GB9921064D0 (en) 1999-09-08 1999-09-08 Drug combination
GBGB9921063.5A GB9921063D0 (en) 1999-09-08 1999-09-08 Therapy

Publications (1)

Publication Number Publication Date
ID30485A true ID30485A (id) 2001-12-13

Family

ID=27269637

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW00200101892A ID30485A (id) 1999-02-06 2000-02-01 Kombinasi obat yang terdiri dari ( e ) 7 [ 4 ( 4 fluorofenil ) 6 isopropil 2 [ metil (metilsulfonil) - amino ] pirimidin 5 il ] (3r,5s) 3,5 dihidroksihept-6- asam enoik dan suatu penghambat, bahat penginduksi atau bahan dari p450 isoenzim 3a4

Country Status (29)

Country Link
US (3) US6982157B1 (ko)
EP (1) EP1185274B1 (ko)
JP (2) JP2002536331A (ko)
KR (2) KR20060117381A (ko)
CN (1) CN1165310C (ko)
AR (1) AR029333A1 (ko)
AT (1) ATE282415T1 (ko)
AU (1) AU767304B2 (ko)
BR (1) BR0007999A (ko)
CA (1) CA2358632C (ko)
CZ (1) CZ301296B6 (ko)
DE (1) DE60015965T2 (ko)
EE (1) EE04929B1 (ko)
EG (1) EG23858A (ko)
ES (1) ES2232418T3 (ko)
GB (1) GB0000710D0 (ko)
HK (1) HK1041817A1 (ko)
ID (1) ID30485A (ko)
IL (1) IL144715A0 (ko)
IS (1) IS2337B (ko)
MX (1) MXPA01007905A (ko)
MY (1) MY130606A (ko)
NO (1) NO320745B1 (ko)
NZ (1) NZ512982A (ko)
PL (1) PL198034B1 (ko)
PT (1) PT1185274E (ko)
TR (1) TR200102228T2 (ko)
TW (1) TWI282738B (ko)
WO (1) WO2000045817A1 (ko)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6489346B1 (en) 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
DE19944803A1 (de) * 1999-09-20 2001-03-29 Bayer Ag Kombination von Dihydropyridinverbindungen und HMG-CoA-Reduktase-Inhibitoren und ihre Verwendung in Arzneimitteln
GB0001621D0 (en) * 2000-01-26 2000-03-15 Astrazeneca Ab Pharmaceutical compositions
GB0003305D0 (en) 2000-02-15 2000-04-05 Zeneca Ltd Pyrimidine derivatives
US8993599B2 (en) 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
GB0322552D0 (en) 2003-09-26 2003-10-29 Astrazeneca Uk Ltd Therapeutic treatment
US9173847B2 (en) 2003-10-10 2015-11-03 Veloxis Pharmaceuticals A/S Tablet comprising a fibrate
CA2540984C (en) 2003-10-10 2011-02-08 Lifecycle Pharma A/S A solid dosage form comprising a fibrate
US8906940B2 (en) 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
KR20070038553A (ko) 2004-08-06 2007-04-10 트렌스폼 파마수티컬스 인코퍼레이티드 신규한 스타틴 약제학적 조성물 및 관련된 치료방법
US20090162316A1 (en) 2005-07-05 2009-06-25 Harvard University Liver targeted conjugates
AU2006329006B2 (en) * 2005-12-20 2013-02-28 Lek Pharmaceuticals D.D. Pharmaceutical composition comprising (E)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl]-(3R,5S)-3,5-dihydroxyhept-6-enoic acid
US20080109252A1 (en) * 2006-11-08 2008-05-08 Lafountain Andrea Predicting patient compliance with medical treatment
US20120130202A1 (en) * 2010-11-24 2012-05-24 Fujitsu Limited Diagnosis and Monitoring of Musculoskeletal Pathologies
US11417416B2 (en) * 2018-06-14 2022-08-16 Astrazeneca Uk Limited Methods for lowering blood pressure with a dihydropyridine-type calcium channel blocker pharmaceutical composition
US20220273652A1 (en) 2019-07-31 2022-09-01 Intas Pharmaceuticals Ltd. Pharmaceutical composition comprising hmg-coa reductase inhibitors and fenofibrate

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2627696B1 (fr) * 1988-02-26 1991-09-13 Fournier Innovation Synergie Nouvelle forme galenique du fenofibrate
JP2648897B2 (ja) * 1991-07-01 1997-09-03 塩野義製薬株式会社 ピリミジン誘導体
EP0521417B1 (de) * 1991-07-02 1994-11-23 Joh. A. Benckiser GmbH Zusammenfaltbare Vorratsflasche
JP3852621B2 (ja) * 1992-01-21 2006-12-06 あすか製薬株式会社 血管内皮細胞機能改善剤
FR2730231B1 (fr) * 1995-02-02 1997-04-04 Fournier Sca Lab Association de fenofibrate et de vitamine e, utilisation en therapeutique
JP4738592B2 (ja) * 1997-10-31 2011-08-03 アーチ・デヴェロップメント・コーポレイション ５α−還元酵素活性を調節するための方法及び組成物

Also Published As

Publication number Publication date
TWI282738B (en) 2007-06-21
AU2121800A (en) 2000-08-25
KR20060117381A (ko) 2006-11-16
PL198034B1 (pl) 2008-05-30
CZ20012844A3 (cs) 2001-11-14
JP2002536331A (ja) 2002-10-29
KR20010101790A (ko) 2001-11-14
NO20013811L (no) 2001-10-02
CA2358632A1 (en) 2000-08-10
DE60015965D1 (de) 2004-12-23
PT1185274E (pt) 2005-03-31
MXPA01007905A (es) 2003-06-04
AR029333A1 (es) 2003-06-25
BR0007999A (pt) 2001-11-06
IL144715A0 (en) 2002-06-30
GB0000710D0 (en) 2000-03-08
CA2358632C (en) 2008-10-28
IS6009A (is) 2001-07-17
US6982157B1 (en) 2006-01-03
EP1185274B1 (en) 2004-11-17
CZ301296B6 (cs) 2010-01-06
US20060040969A1 (en) 2006-02-23
NO20013811D0 (no) 2001-08-03
EE200100406A (et) 2002-10-15
AU767304B2 (en) 2003-11-06
EP1185274A1 (en) 2002-03-13
HK1041817A1 (en) 2002-07-26
DE60015965T2 (de) 2006-01-05
PL364780A1 (en) 2004-12-13
US20090042911A1 (en) 2009-02-12
ATE282415T1 (de) 2004-12-15
EG23858A (en) 2007-11-18
IS2337B (is) 2008-02-15
ES2232418T3 (es) 2005-06-01
NZ512982A (en) 2003-08-29
MY130606A (en) 2007-07-31
EE04929B1 (et) 2007-12-17
NO320745B1 (no) 2006-01-23
TR200102228T2 (tr) 2002-03-21
JP2007277267A (ja) 2007-10-25
CN1165310C (zh) 2004-09-08
WO2000045817A1 (en) 2000-08-10
CN1338936A (zh) 2002-03-06

Similar Documents

Publication Publication Date Title
ID30485A (id) Kombinasi obat yang terdiri dari ( e ) 7 [ 4 ( 4 fluorofenil ) 6 isopropil 2 [ metil (metilsulfonil) - amino ] pirimidin 5 il ] (3r,5s) 3,5 dihidroksihept-6- asam enoik dan suatu penghambat, bahat penginduksi atau bahan dari p450 isoenzim 3a4
AU3569800A (en) Pyrimidine compounds with pharmaceutical activity
FR2811552B1 (fr) Composition notamment cosmetique ou pharmaceutique se presentant sous forme solide
DE59812907D1 (de) Substituierte Isochinolin-3-Carbonsäureamide, ihre Herstellung und ihre Verwendung als Arzneimittel
DE60045168D1 (de) Kombinationspräparate enthaltend (E)-7-Ä4-(4-fluorophenyl)-6-isopropyl-2-Ämethyl(methylsulfonyl)aminoÜpyrimidin-5-ylÜ(3r,5s)-3,5-dihydroxyhept-6-enoic Säure
BRPI0013439B1 (pt) composiÇço compreendendo tramadol e um fÁrmaco anticonvulsivante.
IL163552A (en) Conjugates of biologically active compounds, uses thereof and pharmaceutical compositions comprising the same
AU3813499A (en) The use of dihydropyrimidines as medicaments, and novel substances
PT1169460E (pt) Preparacao de moleculas biologicamente activas.
AU3157801A (en) Beta-amino acid compounds as integrin antagonists
AU1979501A (en) Optically active materials
AU5210798A (en) Nucleic acid construct for expressing active substances which can be activated by proteases, and preparation and use
BR0014465B1 (pt) 1,1'-bifenil-2-carbonamidas 2'-substituÍdas, preparado farmacÊutico e aplicaÇÕes dos referidos compostos.
DE69937573D1 (de) Extrazelluläres, neues rage-bindendes protein (en-rage) und dessen verwendungen
DZ3155A1 (fr) Nouvelle composition pharmaceutique.
AU5073400A (en) Sulfonamide compounds with pharmaceutical activity
AU2759800A (en) Processes and intermediates for the preparation of 1,3-oxazin-6-ones and uracils
CA2379314A1 (en) Tablet for sucking, containing ambroxol
AU5404800A (en) Process for the preparation of optically active n-acyl derivatives of methyl n-(2,6-dimethylphenyl)-d-alaninate
DZ3163A1 (fr) Nouvelle substance pharmaceutique.
AU2002325614A1 (en) Compounds containing lactic acid elements, method for the production and use thereof as pharmaceutically active substances
AU2003244235A1 (en) Process for preparation of optically active 1-substituted amino-2,3-epoxypropanes, intermediates for the synthesis thereof and process for preparation of the intermediates
IL164901A0 (en) Optically active beta-aminoketones, optically active 1,3-aminoalcohols and processes for preparing them
AU1411200A (en) Novel physiologically active substance, process for producing the same and utilization thereof
AU6471800A (en) 4-(substituted phenyl)-5-halopyrimidine derivatives and herbicides containing the same as the active ingredient